Ovarian Cancer
2022-05-19 19:00 - 20:30 (Africa/Nairobi)
SPEAKER PROFILES:
Dr Vineet Talwar
Vineet Talwar is a Medical Oncologist. He currently serves as the Director, Department of Medical Oncology at RGCIRC, New Delhi, India a position he has held since May 2002. He holds a Doctorate of Medicine in Medical Oncology from the Cancer Institute, Adyar, in Chennai.
His areas of interest include: Ovarian Cancer, Breast, Cervical, Pancreatic, Lung, Urinary Bladder, Gallbladder, Stomach, Renal, Chronic Myeloid Leukemia, Acute Myeloid Leukemia, Lymphoma and Testicular Cancer.
Professional Associations:

Fellow of Royal College of Physicians (FRCP) EDINBURGH (U.K).
Fellow of Indian College of Physicians (FICP )
Fellow of International Medical Sciences Academy (FIMSA)
Member European Society of medical Oncology (ESMO)
Member American Society Of Clinical Oncology (ASCO)
Life Member India Society of Oncology (ISO)
Life Member Breast Cancer Foundation India (BCFI)
Life Member Indian cooperative Oncology Network (ICON) Group

Dr Vineet has published widely in peer reviewed journals. He has received numerous national awards in recognition of his work.
Dr Khadija Warfa
Khadija Warfa is a Consultant Gynecologic Oncologist, who completed her gynaecological oncology fellowship at the University of Calgary, Canada.
Currently Dr. Warfa is an Assistant Professor in the Department of Obstetrics and Gynecology at The Aga Khan University Hospital, where she had done her Obstetrics and Gynecology residency training. She is involved in the training and supervision of postgraduate students.
Dr. Warfa is a member of the African Cancer Coalition and European society of gynecologic oncology (ESGO). She is involved in the Harmonized NCCN guidelines and is a technical advisor to the Kenya National cancer treatment protocols with the objective to reduce mortality related to Gynecologic Cancers in Kenya.
Moderator: Dr Benjamin Odongo Elly
Benjamin Odongo Elly is a Senior Lecturer, Obstetrician/Gynaecologist and Gynecologic Oncologist with over 20 years of experience in clinical practice and programmatic leadership of public health initiatives.
He previously served as the Head of Department of Gynaecologic Oncology at Moi Teaching and Referral Hospital (MTRH) Eldoret, a position he had held since completion of Clinical Fellowship Training in Gynaecologic Oncology (Moi University/University of Toronto) including International Gynecologic Cancer Society(IGCS) Global Mentorship Program.
Prior to his current engagement, Dr. Elly was The Technical lead of Prevention of Mother-to-Child Transmission of HIV/Maternal and Child Health (PMTCT/MCH) at the U.S. Centers for Disease Control and Prevention (CDC).
Dr. Elly has held various teaching positions, balancing lectures with clinical duties and student mentorship. He is a published researcher and in the process of developing multiple protocols. He has presented at International and local conferences and participated in various reproductive health discussion forums.
Dr. Elly is the former President of The Kenya Obstetrical and Gynecological Society (KOGS).

Webinar Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

The Economics of Cancer Care
2022-05-26 19:00 - 20:30
SPEAKER PROFILES:
Prof Nazik Hammad
Nazik Hammad is a Professor at the Division of Medical Oncology, Queen’s University, Kingston Health Science Center, Ontario, Canada. She is the Chair of the Education and Training Committee of the African Organization in Research and Training in Cancer (AORTIC). Prof. Hammad is a visiting professor at the University of Nairobi, Kenya. She is the co-chair of the Network for Advancing Black Learners (Medical Students and Residents) in Ontario. She is the former Director of Global Health, Faculty of Health Sciences at Queen’s University. She is an executive member of the Global Oncology Program at Queen’s University. She treats GI, breast and brain tumours.
Prof. Hammad has a keen interest in medical education, in particular health professions education in low and –middle-income countries (LMIC) and cancer workforce development. She has a Master degree in Medical Education in the Health Professions (MEHP) from Johns Hopkins University. She teaches regularly at the Clinical Oncology Training Program in Khartoum, Sudan and as a visiting professor at the Medical Oncology Fellowship Training Program, University of Nairobi, Kenya. Her areas of expertise include training program development and evaluation, accreditation, curriculum development, mentoring and innovations in education. Her work on education has been presented at international conferences and published in peer-reviewed journals. She is a recipient of several grants in education including the Royal College of Physicians and Surgeons of Canada International Development, Aid and Collaboration Grant in 2020 for Faculty Development among African Oncologists. Her other areas of interest include value in cancer care. Together with colleagues in African she led the first Choosing Wisely Africa that was recently published in the Journal of Global Oncology.
Prof Fredrick Chite Asirwa
Fredrick Chite Asirwa M.D. is the CEO of International Cancer Institute, an organization whose main purpose is to expand Education, Clinical Care and Training opportunities in cancer control and research across sub-Saharan Africa (SSA) through multi-sectoral collaborations and partnerships with relevant organizations both governmental and NGOs.
He is a Medical Oncologist & Hematologist, PD/PI of several access to personalized cancer care and research initiatives including Blueprint Program, Shining Tower Program, Clinical Trials Program-all geared towards enhancing early detection, promoting primary HPV screening, providing SOC diagnostics, therapeutics cancer research. He has developed several training programs including SSA Oncology Preceptorship training, Digital Pathology Program, Telemedicine Program, Oncology training for Physician assistants (Clinical Officers), development of Oncology Nursing training program in Kenya, Medical Oncology Fellowship Program and assisted in the development of gynecologic oncology program. . He also conducts Clinical Trials in SSA.
He was previously (2011-2019), the Director of Academic Model Providing Access to Health Care (AMPATH Oncology & Hematology Consortium) in Kenya. In this role he developed infrastructure for telemedicine at AMPATH, created a robust hematology & oncology outreach program in rural Kenya and participated in the development of the Kenya National Cancer Control policies, strategic plans and guidelines by the National MOH. As PI to various clinical and research programs he established Multiple Myeloma program, Lymphoma Program, functional tumor registry, Breast Cancer screening & treatment program, Hemophilia and Sickle cell diagnostics, treatment & research, EMR for Oncology care and screening, a multinational Lung Cancer Control Program, MLCCP (Kenya, South Africa, Lesotho, Tanzania, and Eswatini). He also teaches at various Universities in SSA and participates in Scientific Review Committees (SRC) of various Oncology Clinical Trial Centers in SSA.
He has also been an active ASCO member through ASCO’s Multidisciplinary Cancer Management Course (MCMC), International Affairs Committee (IAC), Education Council, ASCO‘s Academic Global Oncology Task Force and as a Peer reviewer to ASCO Journals. He is currently a member of ASCO-ESMO Global Oncology Curriculum committee and was recently elected by ASCO membership to serve on the Board of Directors of the American Society of Clinical Oncology (ASCO) as the designated International Oncologist for 2022-2026.
He has been recognized for his work to increase access to cancer control for the underserved through various awards including the United States’ National Cancer Institute’s Pearline Global Cancer Research Humanitarian Award, 2020; The Children’s Place International‘s 2018 Hero Award for his pioneering work in treating children and adults with cancers in Kenya. He is the current Interim President of the College of Oncology of East, Central and Southern Africa (ECSA-CO) and a senate member for ECSA Health Community. He is also a distinguished Faculty speaker in both local, regional and International professional conferences and events including ASCO, AORTIC, KESHO, Africa Cancer ECHO, APCA amongst others.
He did his Undergraduate training (Bachelor of Medicine and Bachelor of Surgery) in Kenya and Post-graduate/specialty training (Internal Medicine Residency & Heme/Onc Fellowship) in the United States.
Dr Solomon Matiko Riro
Matiko Riro is a Medical Doctor and a Health Economist, currently supporting a number Sub-Saharan African countries in health financing reforms towards achieving UHC. He has been involved in several advisory and research initiatives focusing on optimizing health outcomes, specifically on cost-effectiveness and budget impact of healthcare interventions in low- and middle-income countries.
Moderator: Dr Mohammed Ezzi
Mohammed Ezzi is a Lecturer and Consultant Medical Oncologist in the Department of Clinical Medicine and Therapeutics at the University of Nairobi in Nairobi, Kenya. He is also the Treasurer for the Kenya Society of Hematology and Oncology (KESHO) and also the Chair for the Educational subcommittee in the same Society.
He did his Internal Medicine residency at the University of Nairobi and subsequently did a two-year fellowship in Medical Oncology at the same university. He is currently a fellow at the College of the European School of Oncology and pursuing a Certificate in Competence in Breast Cancer by the European School of Oncology.
His academic focus is in medical education and is passionate about teaching across the spectrum of medical learners with an interest in enhancing oncologic knowledge among non-oncologist. He has presented at several symposia, workshops and conferences both locally and internationally. He has several publications in peer reviewed international journals. Dr. Mohammed Ezzi is a member of KESHO, ASCO, ESMO, AORTIC and KAP. His key areas of interest include breast cancer, malignant hematology and clinical pharmacology.

Webinar Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Cancer Survivorship
2022-06-02 19:00 - 20:30
SPEAKER PROFILES:
Dr Kelli Gross
Kelli Gross, MD, is a fellowship-trained urologist specializing in Male Infertility and Men’s Health. She completed her undergraduate work at the University of Texas at Austin, graduating with a BA in Studio Art and a BS in Psychology and. She earned her medical degree from the University of Texas Medical Branch and completed her residency at the Mayo Clinic in Arizona. Dr. Gross elected to pursue an additional year of training at the University of Utah focusing on Male Infertility and Men’s Health.
She had extensive training in microsurgery, including Microdissection Testicular Sperm Extraction (microTESE), microscopic varicocelectomy, microsurgical spermatic cord denervation and Vasectomy Reversal. She also received additional training in men’s health procedures such as placement of inflatable penile prosthesis (IPP) and Peyronie’s disease. Her practice consists of Male Infertility, Men’s Health, Erectile Dysfunction, Peyronie’s disease and surgical management of Testicular Pain and Benign Prostatic Hyperplasia.
Prof Daniela Wittmann
Daniela Wittmann is an Associate Professor in the Department of Urology at Michigan Medicine. She is also a certified sex therapist and sex therapy supervisor. Her clinical practice is focused on couples coping with sexual problems after prostate cancer as well as on patients with other sexual problems.
Dr. Wittmann’s research interests center on sexual recovery after urologic cancer treatment. Her research employs mixed methods study design. Dr. Wittmann lectures nationally and internationally on sexual health in chronic illness, she supervises of Michigan Medicine certified sex therapists, mentors trainees and colleagues on mixed methods research and is engaged in education about sexual health topics for patient support groups.
She has published widely on her research topics and is the Associate Editor of the Journal of Sexual Medicine.
Dr Jane Machira
Jane Machira is an Obstetrician and Gynecologist with a passion for fertility treatment. She is the co-founder of Gynacare and also works as a specialist Obstetrician/Gynecologist at Kenyatta National Hospital (KNH).
Dr. Machira holds a Bachelors of Medicine and Surgery, a Masters of Medicine in Obstetrics and Gynecology degree from the University of Nairobi and a Master degree in the Biotechnology of Human Assisted Reproduction and Embryology from the Universitat De Valencia in Spain.
In addition, she has done extensive training both locally and abroad in the areas of gynecology, fertility and laparoscopic surgeries, having attended training in infertility medicine in Gujarat, India and the International School of Medicine in Kiel, Germany, among others.
With over 15 years of experience in reproductive health. She has also lectured at various institutions, including Kenyatta University’s School of Medicine and is currently a consultant Gynecologist at Kenyatta National Hospital and an honorary lecturer in Obstetrics and Gynecology at the University of Nairobi’s School of Medicine.
She is certified by the Kenya Medical and Practitioners Board and is a member of the Kenya Obstetrics and Gynecology Society. She is also a member of the Infertility Committee at KNH, where she is currently involved in setting up an assisted reproductive department that will provide affordable intrauterine insemination (IUI) and IVF services for the public.
Moderator: Muthoni Mate
Muthoni Mate is a professional epidemiologist with over 15 years’ experience in health research and health systems strengthening within the African Continent. Her experience with end-to-end implementation of medical research programs and her aptitude for community-rooted solutions lend themselves very strongly to the type of solutions that Africa is moving towards. This involves the designing and implementing of innovative African health solutions with a global mindset.
Muthoni is a person living with Cancer and her experience crystalized the realities of lack of reliable information, under resources and a fragmented healthcare system on the outcomes of a cancer diagnosis. This redefined her world view and reaffirmed her contribution in the battle against all types of cancer which lead to the establishment of The Cancer Café (www.cancer-cafe.org) – an innovative nonprofit organization that tailor- makes solutions for people living with cancer by linking them to resources and simplified, holistic, credible, consistent information about cancer prevention, management and rehabilitation.
Muthoni has been involved in the generation and implementation of key governance in cancer prevention and management -The Kenya Cancer Policy 2019-2020 and the Kenya National Cancer Control Strategy 2012 – 2020 among others.
She also seats on various technical advisory forums, The National Cancer institute of Kenya and the Non-Communicable Disease ICC Monitoring, Evaluation and Research. She is also a Rotarian – a humanitarian institution with the mission of service above self.

Webinar Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Immunotherapy
2022-06-16 19:00 - 20:30
PEAKER PROFILES:
Dr Joseph Abuodha
MBCHB (MOI), MMED-INTERNAL MEDICINE (AKU), MRCP-UK (EDIN) FELLOW MEDICAL ONCOLOGY
Dr Abuodha obtained his undergraduate degree from Moi University, after which he was involved in clinical trials with KEMRI/CDC and later entered the oncology world at AMPATH-KENYA. He pursued his speciality training in Internal Medicine at the Aga Khan University Hospital, Nairobi and is currently the inaugural Fellow in Medical Oncology at the Department of Haematology and Oncology at the institution after spending a brief period as an instructor.
He is also a member of the Royal College of Physicians of Edinburgh, United Kingdom.
Dr Abuodha has a keen interest in research for health in oncology and building capacity for medical research in the larger Eastern Africa.
Dr Amina Kidee (Moderator)
Dr Amina Kidee is a Medical Oncologist at the Aga Khan University Hospital, Mombasa.
Her interests are in breast cancer, GI malignancy, and translational research.

Webinar Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Hodgkin's Lymphoma
2022-06-30 19:00 - 20:30
SPEAKER PROFILES:
Dr Justin Du Toit
Justin Du Toit is a Clinical Haematologist who trained at UCT and now works in the Bone Marrow Transplant Unit at Wits Donald Gordon Medical Centre.
He is currently working with his colleagues to implement quality management systems in adult and paediatric bone marrow transplantation that will be JACIE-FACT accredited.
Dr Du Toit’s main focus and passion is in bone marrow transplant. He is actively involved in research on haematopoietic stem cell mobilisation, haploidentical stem cell transplantation and donor specific antibodies. Through his research efforts, Dr Du Toit strives towards creating best care algorithms to improve patient outcomes.
Moderator: Dr Beatrice Jepngetich Melly
Beatrice Melly is a Clinical Haematologist at Moi Teaching & Referral Hospital.
She holds a Bachelor’s Degree in Medicine and Surgery from Moi University and a Master’s Degree in Clinical Haematology from Alexandria University, Egypt.
Dr Melly is also the Section Head for Haematology at the Haemato-Oncology Directorate at Moi Teaching and Referral Hospital.
She has over 8 years’ experience in treatment of both benign and malignant Haematological conditions.

Webinar Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Palliative Care
2022-07-07 19:00 - 20:30
SPEAKER PROFILES:
Dr Christian Ntizimira
Christian Ntizimira is the Founder/Executive Director of the African Center for Research on End-of-Life Care (ACREOL), a non-profit organization to bring socio-cultural equality through “Ubuntu in End-of-life Care” in Africa.
He is a Fulbright Alumni and graduated from Harvard Medical School, department of Global Health and Social Medicine. Dr Ntizimira is the winner of the prestigious Tällberg-Stervos Niarcos Foundation-Eliasson Global Leadership Prize 2021, for his passionate advocacy for palliative care in Rwanda and elsewhere in Africa, based on his deeply held belief that dignified end-of-life care is a human right.
He pioneered integration of palliative care and end of life care into health services rendered to Rwandan cancer patients and in the community settings. Through his leadership more than 1500 health care providers and community health workers have learned the principles of cancer prevention control & palliative care leading to a five-fold increase in prescription of morphine, an essential pain medication. In 2016 Dr Ntizimira was awarded as a young cancer leader and world cancer Regional, lead in 2018 for his outstanding contributions in cancer control in Rwanda and in Africa.
He was a member of the scientific Advisory Committee for the Lancet Commission on Global Access to Palliative Care and Pain Control published in 2018 and commissioner for the Lancet Oncology Commission on Cancer in Sub-Saharan Africa published in 2022. In 2018 he became the first advocacy/policy champion among extraordinary individuals who are making a significant contribution to developing palliative care in low- and middle-income countries for World Hospice and Palliative Care Alliance (WHPCA). From 2010–13, he was the director of Kibagabaga Hospital in Kigali.
Mackuline Atieno
Executive Director, Kenya Hospices and Palliative Care Association (KEHPCA)
Mackuline is a Palliative Care Nurse and Medical Anthropologist with over 12 years’ experience in palliative care development. She is passionate about improving health outcomes through research and evidence based practice; and use of technology.
Before Joining KEHPCA, Mackuline worked with the African Palliative Care Association. She has provided technical support and management for more than 10 multi-partnership and multi-country projects in African countries including Botswana, Eswatini, Ghana, Malawi, Mozambique, Namibia, Rwanda, South Africa, Uganda, Zambia, Zimbabwe as well as Kenya.
She has been involved in palliative care policy reviews and development, research and development of palliative care information, education and communication materials and e learning at national and regional levels.
Mackuline holds a Bachelor’s Degree in Nursing, Diploma in Palliative Care, and is completing a Masters in Medical Anthropology.
Moderator: Dr Zipporah Ali
MD, MPH, MPC, HonDUniv
Chair of Non-Communicable Diseases Alliance Kenya
Technical Advisor/Consultant/Researcher
Zipporah Ali has recently retired from the position of Executive Director of Kenya Hospices and Palliative Care Association (KEHPCA), a position she held for 15 years. She serves on the board of several organizations including; Kenya Hospices and Palliative Care Association, International Children’s Palliative Care Network (ICPCN), City Cancer Challenge, Alzheimer/Dementia Kenya, Public Health and Palliative Care International and Kenya Network of Cancer Organizations (KENCO). She has previously served on several other global, regional and national boards.
Dr. Ali has been and continues to be involved in advocacy and creating awareness on pain relief and palliative care in Kenya for children and adults as well as Universal Health Coverage. In her leadership role as the Executive Director for KEHPCA, she was very instrumental in fostering strong relationships with the Ministry of Health to integrate palliative care into government hospitals. She was also instrumental in advocating for palliative care to be included in the undergraduate medical and nursing schools in Kenya. She is a strong advocate for cancer prevention, control and treatment and was instrumental in developing the first National Cancer Control Strategy and the National Guidelines for Cancer Management-Kenya. She has also advocated for palliative care to be integrated in other non-communicable diseases as well as infectious diseases.
Dr. Ali has been involved in a number of activities at the World Health Assembly (Geneva) and the UN High Level Meetings on Non-communicable diseases. She is a strong advocate for right to health for all and a supporter of the movement on meaningful involvement of persons living with serious health conditions and leaving no one behind.
Dr. Ali holds an MD from Ege University, Izmir, Turkey, a Master’s Degree in Public Health from the University of Nairobi, a Higher Diploma in Palliative Care from Oxford Brookes University and a Masters in Palliative Care from the University of Dundee. She has completed the International Pain Policy Fellow program with the International Pain Policy Studies Group (WHO Collaborating Centre for Policy and Communication in Cancer Care, University of Wisconsin) as well as Higher Diploma in the International Palliative Care Leadership Development Initiative at The Institute of Palliative Medicine at the San Diego Hospice.
She has received a number of awards in recognition of her work nationally and globally. These include:

Doctor of Law Honoris Causa-University of Dundee (2018)
International Humanitarian Award-Women4Africa (2018)
Social Impact Award for the Sub-Saharan Africa region-British Council (2018)
Honorary Doctor of the University by Oxford Brookes University (2012)
Individual Advocacy Award by the African Palliative Care Association and Open Society Foundations (2013
African Palliative Care Award –(In recognition for being on the interim board and later serving on the board for 2 terms) -2007

Webinar Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Gastric Cancer
2022-07-14 19:00 - 20:30
SPEAKER PROFILES:
Dr Manel Haj Mansour
Manel Mansour is a Consultant Physician and board certified Medical Oncologist currently working at the Aga Khan University Hospital. She was formerly a consultant medical oncologist at Texas Cancer Centre, Nairobi and also worked as a consultant medical oncologist and a lecturer at Abderrahmen University Hospital, Tunisia.
Dr. Mansour graduated from the Faculty of Medicine of Tunis in 2012 and completed medical oncology residency in 2017.
She holds:

A certificate of completion of Oncologic Science Course on line in Breast Cancer Treatments from The Africa Breast University.
A certificate of medical oncology training on XXXIIth course antitumor chemotherapy and cancer medical treatment at Gustave Roussy Institute Paris, France.
A post graduate certificate in Prevention and Palliative Care in Oncology, Faculty of Medicine of Sousse.
A post graduate certificate in Thoracic Oncology, Faculty of Medicine of Tunis.
A post graduate certificate in Breast Disease, Faculty of Medicine of Tunis.

She is a member of ESMO, ASCO, STOM (Tunisian Society of Medical Oncology) and KESHO. Her areas of interest include breast cancer, lung cancer, gastrointestinal cancers, gynecological and genitourinary cancers.
Dr Abdi Hakin Mohamed
MD, M.Med, FCS (ECSA)
Abdi Hakin Mohamed is a Surgical Oncologist and Consultant Laparoscopic Surgeon based in Mombasa.
He did his Surgical Residency at the Aga Khan Hospital, Nairobi and Surgical Oncology Fellowship at the prestigious Memorial Sloan- Kettering Cancer Centre in New York, USA where he was the first ever Clinical Fellow from the African continent. At Memorial Sloan Kettering, he worked with world-renowned colorectal surgeons and was involved in research projects in the institution as well as operating on patients using the most highly advanced surgical equipment, including Robotic Colorectal Surgery for colon and rectal cancer. Dr Abdi has been part of local colorectal cancer trials with his mentor the late Prof Saidi Hassan, and has published the most widely quoted colorectal cancer study in East Africa.
Dr Abdi works both in the private sector and public sector. He is the Chair of Surgery at the Aga Khan Hospital in Mombasa, and is currently involved in treating cancer patients who need surgery in Mombasa. He is the coordinator of the fellowship division of the COSECSA (College of Surgeons of East, Central and Southern Africa) surgical training program at Coast General Teaching and Research Hospital which is the largest COSECSA program in East Africa.
Moderator: Dr Irene Weru
Irene Weru has worked at Kenyatta National Hospital since 2003 and is current Head of Pharmaceutical Products. She holds a master’s degree in Clinical Pharmacy with sub-specialization in oncology pharmacy from the University of Nairobi.
Dr. Weru is a member of various National and international technical working groups including Demand Forecasting and Quantification TWG of the Coalition for Access to NCD Medicines, ChemoSafe Regional TWG, Pharmacy Advisory Council -Global HOPE Pediatric Hematology /Oncology Centers of Excellence and NCI-Kenya Quality Management Expert Working Group.
Dr. Weru is a member of several professional associations including HOPAK, PSK, KESHO and ISOPP. She is the current Secretary to the International Society of Oncology Pharmacy Practitioners (ISOPP).
Besides oncology, Dr. Weru has interest in medicines management and use especially medicine formulary management. She is also an honorary lecturer at University of Nairobi, School of Pharmacy and provides research and clinical practice supervision to undergraduate and postgraduate students.

Webinar Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

East African Colorectal Cancer Summit
2022-07-28 18:00 - 21:00
SPEAKER PROFILES:
DR ANDREW ODHIAMBO
MBChB, MMed(Int.Med), MedOnc(UK), FRCP Edin, FCP (ECSA)
Andrew Odhiambo is a board certified Consultant Physician & Medical Oncologist at the Prime CancerCare Clinic – Nairobi. He is the Unit Head for Medical Oncology at the University of Nairobi (UON). Dr. Andrew holds a Master’s degree in Internal Medicine from the UON. He later did his Fellowship in Medical Oncology in the United Kingdom and is certified by the Federation of Royal College of Physicians of the United Kingdom (RCP-UK), The Association of Cancer Physicians (ACP) and the European Society for Medical Oncology (ESMO). He is a Fellow of the Royal College of Physicians of Edinburgh as well as the East, Central & Southern Africa College of Physicians.
He is the former Secretary and Treasurer of Kenya Society of Haematology & Oncology (KESHO). Dr Andrew is a member ASCO, ESMO & AORTIC. He serves as an expert advisor for local and international bodies i.e. MOH, Kenya Cancer Prevention TWG, and various international Cancer Treatment Guidelines Committees. He has published several articles on cancer in both international and local peer reviewed scientific journals. Dr Andrew has attended over 50 oncology meetings both local and international. He has made over 40 oral presentations and continuously supports Oncology Multidisciplinary team meetings in various top hospitals in Nairobi.
Dr Andrew was awarded the prestigious Business Daily Africa Top 40 under 40 men in the year 2017. He is passionate about cancer education and awareness especially through digital platforms. He has over 60 appearances in mainstream local and international TV, Radio and print media promoting cancer awareness. Key areas of sub-specialization and interest include Gastrointestinal cancers, Pancreatic, Liver & Bile Duct cancer, Metastatic Breast Cancer, Lymphoma, Cancer of Unknown Primary as well as newer treatments i.e. Immunotherapy & Targeted therapy.
For his full profile, please visit www.drandrewodhiambo.com
DR JERRY NDUMBALO
MD MMED Onc (SA) MBA
Jerry Ndumbalo is a Consultant Clinical and Radiation oncologist, Lecturer, and Researcher at Ocean Road Cancer Institute and MUHAS with over 15 years of clinical experience and is currently the Founder and First President of the Tanzania Oncology Society (TOS).
Dr Ndumbalo is a holder of a Doctor of Medicine degree from the University of Dar es Salaam in 2006, Masters of Medicine (MMED) in Radiation and Clinical Oncology from the University of Witwatersrand, South Africa, in 2016, and a Masters of Business Administration (MBA-General Management) from the University of Dar es Salaam, Tanzania, in June 2022.
With vast research interests in clinical research and global health, he has published over 15 articles in peer-reviewed international journals. He is currently serving as a Principal and Co-investigator on numerous projects, including Guideline development and implementation studies, Cervical Cancer and HIV (BMSF), Automated Contouring and Planning (AROMA-C), and Breast CHARTA study.
He has actively participated in and led several technical working groups, including the African Cancer Coalition (ACC), which partners with NCCN in developing Harmonised Cancer Treatment Guidelines for Sub-Saharan Africa. In this Coalition, he chaired the cervical cancer working group. He was a member in developing NCCN harmonized treatment guidelines for Esophageal, Gastric, Colorectal, Ovarian, Prostate, ALL, and AML. He also chaired the technical work to establish the 1st Tanzania National Cancer Treatment Guidelines in 2020. To ensure its utilization, he led ORCI/UCSF team to develop implementation strategies to increase the guideline uptake in Tanzania. He is a reviewing committee member for the Standard Treatment Guidelines (STG) and National Essential Medicines List for Tanzania.
Dr. Ndumbalo is a member of the American Society of Clinical Oncology (ASCO) and was recently awarded International Development and Education Award (IDEA 2022). He is a member of the Africa Organisation for Research and Training in Cancer (AORTIC), serving on its Research Committee in 2020/2021. He also holds membership in the European Society of Medical Oncology (ESMO), the American Society of Radiation Oncology (ASTRO), and the American Association for Cancer Research (AACR). He is a board member of the Tanzania Non-Communicable Diseases Association (TNCDA).
DR FRED OKUKU
MBChB (MUK), MMED (MUK), HAMPT (UW, USA), FCP (ESACOP)
Fred Okuku is a Consultant Physician/Medical Oncologist and the current Head of the Solid Tumor and Private Patient Services, at the Uganda Cancer Institute (UCI). He is a Research Investigator with the Hutchinson Cancer Research Institute-Uganda in Kampala and a Co-PI on the AMC 098 NCI-NIH, a Nelfinavir clinical trial in Kaposi Sarcoma patients at the UCI.
Dr Okuku is a Research Investigator with John Hopkins Program on Liver Cancer in Uganda. He is also a co-investigator on the U54 Lung cancer – HIV study a collaboration between Makerere University and Case Western University (CWRU), Cleveland and a local PI of a phase III, randomized, open-label, multicenter study evaluating the efficacy and safety of adjuvant giredestrant compared with physician’s choice of adjuvant endocrine monotherapy in patients with estrogen receptor-positive, HER-2‑negative early breast cancer.
Dr Okuku has accomplished a number of research projects both locally and collaboratively.
DR NJOKI NJIRAINI (MODERATOR)
Njoki Njiraini is a Consultant Clinical Oncologist based at the Cancer Treatment Centre in The Nairobi Hospital.
She has been key in instituting multidisciplinary meetings, problem oriented research in the department, and streamlining patient care within the oncology clinics in the public and private sector.
Dr Njiraini holds a Bachelor’s degree in Medicine and Surgery from the University of Nairobi, a Master’s Degree in Radiation Oncology from the University of Cape Town, is a Fellow of the College of Radiation Oncology (FCRO) South Africa and a graduate of the Harvard POETIC Fellowship programme.

Webinar Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Haematology
2022-08-04 19:00 - 20:30
SPEAKER PROFILES
Dr Laura Kirui
MBChB BSc FRCP Edin FRCPath
Dr. Laura Kirui is a Consultant Haematologist, in the Department of Haematology-Oncology at Aga Khan University Hospital Nairobi.
Alongside her work in malignant haematology she has a special interest in haemostasis and thrombosis and obstetric haematology. In her role as Clinical Lead for haemostasis and thrombosis she is working to expand this service at AKUHN with new dedicated clinics, guidelines and expanded laboratory testing.
Prior to this Dr Kirui was a Consultant Haematologist/ Haemato-oncologist at the North Middlesex University Hospital, UK working in malignant and benign haematology and heading the Transfusion and Haematology laboratory.
Dr. Kirui underwent specialist training in Haematology at University College London Hospital where she received her Certificate of Completion of Training.
She is a Fellow of the Royal College of Pathologist, UK and a Fellow of the Royal College of Physicians and has a Bachelor’s of Medicine and Surgery from the University of Leeds, UK with an intercalated BSc in International Health.
Moderator: Dr Anne Mwirigi
MBChB, MRCP, FRCPath (UK)
Dr Mwirigi is a consultant haematologist working at the Aga Khan University Hospital in Nairobi, Kenya. She obtained her undergraduate MBChB from the University of Glasgow in 2002. After her house jobs and a medical rotation in Glasgow, she moved to London in February 2007.
Her career in Haematology began as a senior house officer at King’s College Hospital, following which she was accepted on the Guy’s and St Thomas’ NHS Trust Specialist Registrar Rotation in 2009. She obtained her certificate of completion of training in 2014, and thereafter took on consultant haematologist positions for a period of two and a half years at both Guy’s and St Thomas’ and King’s College Hospitals.
Dr Mwirigi has a passion for haematology and always planned to practice haematology in her country of birth, Kenya. Since moving back in December 2016, she has engaged with haematopathologists and clinical haematologists in the region, and is involved collaborative ventures aimed at improving the quality of haematology services in Kenya. She was a key member of the scientific committee which organised the Haematology and Oncology Society of Africa 3rd inaugural conference held in Nairobi in August 2017.

REGISTER

Liver Cancer
2022-08-11 19:00 - 20:30
SPEAKER PROFILES:
Prof Mohamed Farouk Mostafa
Mohamed Farouk graduated from Alexandria Medical School in 1992.
Prof. Farouk joined the Alexandria Clinical Oncology Department ACOD in 1994, starting the journey from resident till becoming Professor of Clinical Oncology in the year 2018.
Prof Farouk has more than 30 publications in the field of oncology; some of them published in level A journals. He participated as a co-investigator in the grant from STDF, Egypt. He has attended several advisory boards for different Pharma companies.
His areas of interest include GIT malignancy, breast and Gynaecology cancer.
Dr Mercy Gatua
Mercy Gatua is a Medical Oncologist at the Kenyatta University Teaching Research and Referral Hospital. She received her Medical Oncology Fellowship from the University of Nairobi in 2019. Prior to that, she earned her MMED in Internal Medicine at the same university (UON).
Her main interests are in the management of acute leukemia’s, GI malignancies and Cervical Cancer. She also has an interest in research geared to understanding the genetic basis of cancer.
Moderator: Dr Abeid Athman
Abeid Omar is a consultant Clinical (medical and radiation) Oncologist and Nuclear Medicine based in Kilifi, Kenya. Besides, he consults for International Cancer Institute – ICI Eldoret, Kenya. He has keen interest in breast cancer in young women, oncofertility, breast cancer research, radiotherapy, advocacy and Global Oncology particularly in LMIC.
Dr. Abeid completed his training in Clinical Oncology and Nuclear Medicine in Alexandria University Egypt in 2021. He is a fellow of College of European School of Oncology (ESCO) and he has also successfully passed the ESMO exam to become a certified ESMO oncologist.
Dr. Abeid has conducted researches, presented abstracts in ESMO, ASCO, ESTRO, St. Gallen, KESHO conferences and Aga Khan Symposium, published in peer reviewed journals about breast cancer in young women, pregnancy associated breast cancer, pregnancy after breast cancer among others under the close guidance of Prof. Hatem Azim, who has been mentoring him since 2019.
Dr. Abeid is an active member of several societies including KESHO – where he also serves as a member of the education committee, ASCO, ESMO, ESCO, Society of Toxicology. In 2019 he was awarded the ASCO Virtual Mentorship Program and currently he is under the mentorship of College of European School of Oncology. Besides, Dr. Abeid serves as a reviewer for several journals.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Unique presentations of Malignant Lymphoma
2022-08-18 19:00 - 20:30
SPEAKER PROFILES:
Dr Andrew Odhiambo
MBChB, MMed(Int.Med), MedOnc(UK), FRCP Edin, FCP (ECSA)
Consultant Physician & Medical Oncologist – Prime CancerCare Clinic Nairobi.
Thematic Unit Head – Medical Oncology & Lecturer University of Nairobi (UON)
Andrew Odhiambo is a board certified Consultant Physician & Medical Oncologist at the Prime CancerCare Clinic – Nairobi. He is the Unit Head for Medical Oncology at the University of Nairobi (UON). Dr. Andrew holds a Master’s degree in Internal Medicine from the UON. He later did his Fellowship in Medical Oncology in the United Kingdom and is certified by the Federation of Royal College of Physicians of the United Kingdom (RCP-UK), The Association of Cancer Physicians (ACP) and the European Society for Medical Oncology (ESMO). He is a Fellow of the Royal College of Physicians of Edinburgh as well as the East, Central & Southern Africa College of Physicians.
He is the outgoing Secretary & former treasurer of Kenya Society of Haematology & Oncology (KESHO). Dr Andrew is a member ASCO, ESMO & AORTIC. He serves as an expert advisor for local and international bodies i.e. MOH, Kenya Cancer Prevention TWG, various international Cancer Treatment Guidelines Committees. He has published several articles on cancer in both international and local peer reviewed scientific journals. Dr Andrew has attended over 50 oncology meetings both local and international. He has made over 40 oral presentations and continuously supports Oncology Multidisciplinary team meetings in various top hospitals in Nairobi.
Dr Andrew was awarded the prestigious Business Daily Africa Top 40 under 40 men in the year 2017. He is passionate about cancer education and awareness especially through digital platforms. He has over 60 appearances in mainstream local and international TV, Radio and print media promoting cancer awareness. Key areas of sub-specialization and interest include Gastrointestinal cancers, Pancreatic, Liver & Bile Duct cancer, Metastatic Breast Cancer, Lymphoma, Cancer of Unknown Primary as well as newer treatments i.e. Immunotherapy & Targeted therapy.
For his full profile, please visit www.drandrewodhiambo.com
Moderator: Dr Kevin Makori
Kevin Makori is a Clinical Oncologist at the International Cancer Institute Care and Research Clinic (ICI-CRC), Eldoret Kenya. He is involved in cancer patient care and several ongoing immunooncology and haematology clinical trials as a sub investigator at ICI, under the mentorship of his PI and Director, Prof Chite Asirwa. He also heads the Education and Training Office at the Institute, and is involved in teaching and coordination of various oncology capacity building activities. Dr Makori is also a visiting Clinical Oncologist at Tenwek Hospital and a member of the Hospital’s oncology multidisciplinary team.
He received his postgraduate training (MMed Clinical Oncology) at Muhimbili University of Health & Allied Sciences, a program domiciled at Tanzania’s national oncology referral centre, Ocean Road Cancer Institute, Dar es Salaam.
Dr Makori is a member of the Kenya Society of Haematology and Oncology (KESHO), a Global LMIC Associate (Non-Training) Member of the Royal College of Radiologists (RCR) and ASCO. He is a Junior Associate Editor of the RCR’s Clinical Oncology Journal and a current beneficiary of the Journal’s Junior Assistant Editor Mentorship Programme.
His key professional interests are in radiation sciences, immuno-oncology, clinical trials and oncology education.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Prostate Cancer: Active surveillance in Prostate Cancer
2022-08-25 19:00 - 20:30
SPEAKER PROFILES:
Dr Njoki Njiraini
Dr Njiraini is a Consultant Clinical Oncologist based at the Cancer Treatment Centre in The Nairobi Hospital.
She has been key in instituting multidisciplinary meetings, problem oriented research in the department, and streamlining patient care within the oncology clinics in the public and private sector.
Dr Njiraini holds a bachelor’s degree in Medicine and Surgery from the University of Nairobi, a Master’s Degree in Radiation Oncology from the University of Cape Town, is a Fellow of the College of Radiation Oncology (FCRO) South Africa and a graduate of the Harvard POETIC Fellowship programme.
Dr David K. Kimani
MBChB, MMed General Surgery UON (2007)
Dr. Kimani is a Consultant Urologist at Kenyatta National Hospital in Kenya, and an Honorary Lecturer in the Department of Surgery at the University of Nairobi. He did his Clinical Fellowship in Urology at the Global Health Institute Chennai, India in 2014. He has keen interests in Prostate Care and Kidney Transplantation.
Dr. Kimani is a Member of the Surgical Society of Kenya (SSK), Kenya Association of Urological Surgeons (KAUS), Society for International Urologists, (SIU), and the American Urological Association (AUA).
Moderator: Dr Regina Nanzia Ojiwa
Regina Nanzia Ojiwa is a Consultant Clinical Oncologist based at the Cancer Treatment Centre in Kenyatta National Hospital.
She holds a Bachelor’s degree in Medicine and Surgery from Moi University and a Master’s degree in Clinical Oncology and Nuclear Medicine from Alexandria University, Egypt.
Dr Nanzia has key interest in Esophageal, Colorectal and Prostate cancer.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Conducting Cancer Clinical Trials In East Africa Are We Ready?
2022-09-01 19:00 - 20:30
SPEAKER PROFILES:
Professor Mansoor Saleh
Mansoor Saleh, MD received his early education in the Aga Khan School system in East Africa, his medical education at the University of Heidelberg in Germany and conducted his doctoral research at the Max Planck Institute for Medical Research in Heidelberg. He received his training in internal medicine at the Henry Ford Hospital in Detroit Michigan and clinical and translational research training in Hematology & Oncology at the University of Alabama Comprehensive Cancer Center in Birmingham, Alabama where he was tenured Professor of Medicine & Pathology and Director of the First-in-Human Early Drug Development Program.
His area of research and clinical focus is “targeted therapy of cancer”. In January 2020, he joined the Aga Khan University in Nairobi, Kenya as the Founding Chair, Department of Hematology – Oncology and Founding Director – AKU, N Cancer Center.
Moderator: Dr Sitna Mwanzi
Sitna Ali Mwanzi is a consultant medical oncologist working at the Kenyatta National Hospital in Nairobi Kenya. She obtained her Bachelor of Medicine and Surgery from the University of Nairobi and Master of Medicine in Internal Medicine from the Aga Khan University Hospital, Nairobi. She undertook a fellowship in Medical Oncology at Barts Health NHS Trust in the United Kingdom attaining a Specialist Certificate in Medical Oncology from the Royal College of Physicians and Association of Cancer Physicians in the United Kingdom. She also has a Master of Science in Advanced Oncology from Ulm University in Germany.
Her research interests include breast cancer, lung cancer, prostate cancer, chronic myeloid leukemia and cervical cancer. She is passionate about increasing health care workers and general public awareness about cancer, role of screening, early diagnosis and treatment of cancer. She works closely with the National Cancer Control Program in implementation of the National Cancer Control Strategy and advising on cancer policy for improving access to cancer care.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Childhood Cancer
2022-09-08 19:00 - 20:30
SPEAKER PROFILES:
Dr, S. P. Yadav
Dr Yadav is currently working as the Director of Pediatric Hemato Oncology & Bone Marrow Transplant at Medanta Hospital Gurugram India. He holds a Bachelor of Medicine and Surgery from University College of Medical Sciences. He has a Diploma in Child Health from Maulana Azad Medical College, D.N.B (Pediatrics) from Sir Ganga Ram Hospital, Delhi. Fellow in Pediatric Hemato-Oncology, Royal Alexander Hospital for Children, Westmead Australia
His clinical focus is primarily Pediatric Leukemia and Bone Marrow transplantation. He has a goal to make BMT available and affordable to all those who need it. With a rich experience of more than 24 years he has performed over 400 blood & marrow transplants including 50 unrelated donor/cord transplant and 50 Haplo identical bone marrow transplants.
Dr Yadav is an accomplished editor on Oncopedia, and has worked on the editorial front for cure4kids, St. Jude’s Hospital USA, he has also been endowed with ANZCCSG scholarship and he presented a paper during SIOP meeting in Brisbane. He successfully worked as the national co-coordinator on National Training Program in Practical Pediatric Hematology (NTPPPH), and as a secretary for Organ Transplant Group, Indian Academy of Pediatrics. He was awarded with the prestigious Dr CK Bhalla Award in the year 2002
His areas of interest include pediatric leukemia, pediatric blood disorders, pediatric oncology, and blood & marrow transplantation.
Dr Yadav is a member of:
· American Society of Hematology (ASH)
· American Society of Clinical Oncology (ASCO)
· International Society of Pediatric Oncology (SIOP)
· Pediatric Hemato-Oncology (PHO)
· Chapter of Indian Academy of Pediatrics (IAP)
Dr Yadav has published widely in national and international journals.
Dr Deborah Omeddo
Dr. Deborah Omeddo is a Paediatric Haematologist and Oncologist working in Kisii Teaching and Referral Hospital.
She holds a Master’s in Paediatrics and Child Health from the University of Nairobi. She did her fellowship training at Makerere University.
Dr Omeddo strives to provide quality health services to children living with cancer and blood diseases. Her vision is that all children in Kenya will have access to quality healthcare services regardless of location and socio-economic status.
Moderator: Dr Irene Nzamu
Dr Irene Nzamu is a Pediatric Hematologist Oncologist and Head, Pediatric Hemato Oncology Unit, Kenyatta National Hospital.
She completed her undergraduate training (MBChB) and postgraduate training (M.MED) at University of Nairobi. She did her Fellowship in Pediatric Hematology and Oncology at Makerere University in collaboration with Baylor College of Medicine & Global HOPE Texas Children’s Hospital.
Dr Nzamu is passionate about offering evidence based, affordable care for children with cancer & blood diseases in our resource limited settings.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Prostate Cancer
2022-09-15 19:45 - 20:45
SPEAKER PROFILES:
Prof Mack Roach
Professor Mack Roach III, MD, is a Professor of Radiation Oncology, Medical Oncology and Urology, at the University of California, San Francisco. Roach earned his MD from Stanford University School of Medicine. His major research interest involves the application of 3-D conformal and intensity modulated radiotherapy (IMRT) treatment planning technology as a major component of combined modality management of prostate cancer and other solid tumors. Over the last 10 years, his research efforts have been directed at defining optimal imaging modalities, as well as criteria for defining target volumes and improved treatment techniques.
Prof Roach chaired one of the most important large prospective randomized trials comparing different strategies for locally advanced prostate cancer. He has gained international recognition as an authority on treatment planning for prostate cancer and served as senior author for the guidelines for treatment planning recently published by the American College of Radiology.
Prof Roach is a member of several professional societies including the American Society of Clinical Oncology, American Society for Therapeutic Radiology and Oncology, Radiation Therapy Oncology Group, the NCI IMRT Working Group and American Joint Commission for Cancer (AJCC) Staging (GU), the American Cancer Society (ACS) Task for Cancer Screening Guidelines (Prostate cancer) and the NCI Concept Evaluation Panel (Prostate Cancer Phase III Trials).
Prof Silke Gillessen
Professor Silke Gillessen is a Medical Oncologist with focus on genitourinary cancer.
She completed her training in Basel, St. Gallen, and the Dana Farber Cancer Institute, Boston. After returning to Switzerland, she built up the medical oncology unit for genitourinary cancer and headed the clinical research unit for oncology/haematology in Cantonal Hospital, St Gallen.
She served for two terms as president of the SAKK GU group, she chaired the EORTC Genitourinary Cancers Group, and has founded the Advanced Prostate Cancer Consensus Conference (APCCC).
Since 2018, Prof Gillessen has been Genitourinary Cancer Systemic Therapy Research Chair at the University of Manchester and Honorary Consultant at The Christie Hospital, while continuing to work as Consultant in the Department of Oncology/Haematology at the Kantonsspital St. Gallen, Switzerland.
In January 2020 Prof Gillessen was appointed Head of the Department of Medical Oncology, full professor at the Università della Svizzera Italiana (USI) in Lugano and Director of the Oncology Institute of Southern Switzerland (IOSI) in Bellinzona, Switzerland.
Dr Samuel Nguku
Dr Samuel Nguku is a Consultant in Radiology and Nuclear Medicine at Aga Khan University Hospital Nairobi.
He has a master’s degree in Radiology from Aga Khan University and fellowship in Nuclear medicine from Imperial College London.
Dr Nguku was integral in setting up of the first PET CT service in Kenya at the Aga Khan University Hospital Nairobi.
He has great passion in improving cancer imaging in the country and integrating molecular imaging in management of cancer patients.
Moderator: Dr Angela Waweru
Dr Angela Waweru is a Consultant Clinical Oncologist and Section Head of Radiation Oncology at Aga Khan University Hospital, Nairobi.
She graduated from the University of Sheffield and undertook her Core Medical and Clinical Oncology training in Sheffield Teaching Hospitals NHS Trust where she received her certificate of completion of training in 2015 and thereafter took on a Consultant Clinical Oncologist position within the same trust.
She is passionate about increased uptake of advanced radiation technological advances that achieve better outcomes and less toxicity. She has been instrumental at starting advanced radiation services at a leading health care facility in Nairobi. She has also promoted public private partnerships within radiation oncology and in 2022 started a pathway for treating patients requiring more conformal techniques of treatment not readily available at their institutions.
Dr Waweru is keen on promoting radiotherapy governance, she has started radiotherapy safety committees, peer review meetings and service development projects that benchmark local activities against standard guidelines.
She is a Fellow of the Royal College of Radiologist (Clinical Oncology faculty), Member of the Royal College of Physicians and Kenya Society of Haematology and Oncology.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

CML - Choosing the Next Treatment
2022-09-22 19:00 - 20:30
SPEAKER PROFILES:
Dr Charles A. Schiffer, MD
Charles A. Schiffer, MD, is Professor of Medicine and Oncology at Wayne State University School of Medicine and the Karmanos Cancer Institute in Detroit, Michigan. He is the director of the Leukemia/Lymphoma Multidisciplinary Program.
Dr. Schiffer earned his BA cum laude at Brandeis University and his M.D. at New York University School of Medicine. He completed his internship, residency, and chief residency in Internal Medicine at Bellevue Hospital under the auspices of New York University School of Medicine and had subsequent training and positions at the Baltimore Cancer Research Institute, National Cancer Institute and the University of Maryland School of Medicine, where he served as Chief of the Division of Hematology. He has also served as Chief of the Division of Hematology/Oncology and Director of Clinical Research at the Karmanos Cancer Institute.
Dr. Schiffer has authored and co-authored more than 300 articles and 80 book chapters on topics concerning the treatment of leukemia in adults, platelet transfusion, and granulocyte transfusion therapy, among others. He has served on the Editorial Boards for Blood, the Journal of Clinical Oncology, International Journal of Hematology, Transfusion Medicine Reviews and Transfusion, and reviews articles for multiple journals. Committee memberships have included Chairman of the Leukemia Committee of the Cancer and Leukemia Group B, Chairman of the Food and Drug Administration Oncologic Drug Advisory Committee, and grant reviews for the NCI and Leukemia/Lymphoma Society of America. Dr. Schiffer has been named among American Health Magazine’s and Castle Connelly’s “Best Doctors in America,” “Best Cancer Specialists in the US.” In 2006, he received the Dr. John J. Kenney Award from the Leukemia/Lymphoma Society of America and the Celgene Award for Career Achievement in Hematology. He has received multiple teaching awards from Wayne State University and was recently inducted into the Academy of Scholars, the highest recognition accorded to academic faculty at the University.
Dr Matilda Ong’ondi
Matilda Ong’ondi is a Consultant Physician and Clinical Hemato-Oncologist at the Kenyatta National Teaching and Referral Hospital, Kenya’s oldest and largest hospital. She holds a Bachelor of Medicine and Bachelor of Surgery (MBChB) degree (2005) and a Master of Medicine (MMed) degree in Internal Medicine (2010), both from the University of Nairobi. She is registered with the Kenya Medical Practitioners and Dentists Council as an Internal Medicine Specialist.
Dr. Matilda pursued her Clinical Hemato-oncology training at the Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Australia in 2017. In addition, she has undertaken various short Fellowship opportunities through the following institutions: International Chronic Myeloid Leukemia Foundation (Royal Adelaide Hospital and SAHMRI Adelaide, 2017); American Society of Hematology, Visitor Training Program at The Cancer Therapy and Research Centre, San Antonio Texas (2014); and Mayo Clinic, Rochester, Minnesota (2010).
Her main interests are: Multiple Myeloma; Acute Leukemia; Chronic Leukemia; and Platelet disorders. Her other interests are Psycho-Oncology and Clinical Research. She is also passionate about clinical bedside teaching and mentorship.
Dr. Matilda is a member of various societies: Kenya Society of Hematologists and Oncologists (KESHO); European Hematology Association (EHA); and International Society of Thrombosis and Hemostasis (ISTH). In addition, she served as a member of the bodies that developed the Kenya National Cancer Guidelines and NCCN Harmonized Guidelines.
Moderator: Dr Angela McLigeyo
Angela McLigeyo is a licensed Physician and Medical Oncologist practicing in Kenya. She has a Master of Medicine in Internal Medicine from the University of Nairobi, a M.Sc. in Clinical Oncology from Ulm University (Germany), and a Fellowship in Medical Oncology from the University of Nairobi. In addition, she obtained a 5-year board certification in Medical Oncology from ESMO in 2019. She has over 17 years of experiences in hospital and clinical settings.
She is a member of the Kenya Society of Haematology and Oncology (KESHO), European Society of Medical Oncology (ESMO) and American Society of Clinical Oncology (ASCO). She is also a fellow of the East, Central and Southern Africa College of Physicians.
Her core skills are in clinical decision making in internal medicine and oncology, conducting trainings, streamlining medical education and conducting research as well as participation in the development of treatment guidelines and protocols.
Dr McLigeyo currently provides comprehensive oncology healthcare at both public and private health facilities, conducts research in oncology and internal medicine when opportunities arise, and is engaged in teaching internal medicine and oncology at the Kenyatta University. She has authored several research articles in peer reviewed journals and presented abstracts at several conferences.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Breast Cancer Policy in Kenya
2022-10-04 19:00 - 20:30
SPEAKER PROFILES:
Dr Mary Nyangasi
Mary Nyangasi is a medical doctor and global health physician with a 17-year career experience in medical practice, clinical and preventive oncology, cancer policy formulation and programming at the Ministry of Health in Kenya. She currently serves as the Head of the National Cancer Control Program and Co-Chair of the National Cancer Taskforce.
She is passionate about improving access to care across the cancer care continuum and health system strengthening to ensure delivery of services in a timely, safe and effective manner. She has led the formulation and implementation of various cancer policy documents and guidelines including the Breast Cancer Screening and Early Diagnosis Action Plan 2021-2025. Globally, she has also contributed to the drafting of the Global Strategy for Elimination of Cervical Cancer abd the Global Breast Health Initiative. She has interest in cancer research especially in the area of preventive oncology and behavioural studies and have published a number of papers in various peer-reviewed journals.
Dr Nyangasi is a member of the Kenya Medical Association, the Africa Cancer Coalition, the Kenya Red Cross and the Kenya Society of Haematology and Oncology.
Dr Daniel Ojuka
Daniel Ojuka is a Lecturer & Oncoplastic Breast and Endocrine Surgeon, University of Nairobi & Kenyatta National Hospital.
He holds a Bachelor of Medicine and Surgery from the University of Nairobi and Masters of Medicine in Surgery from the same institution.
Dr Ojuka is the current President of the Surgical Society of Kenya.
Moderator: Dr Naftali Busakhala
Naftali Busakhala is a senior lecturer and specialist physician at Moi University and Moi Teaching and Referral Hospital. He is the departmental postgraduate coordinator at the department of pharmacology and toxicology at Moi University. He is the co-chairman of the Ampath Oncology working group. Dr Busakhala is the principal investigator of the AIDS Malignancy Consortium, Moi University Site. He is also the principal investigator of the Lung and Breast Cancer Projects.
Dr Busakhala is a senior research fellow at the Institute of Prevention and Research, Lyon France. He has published widely in peer reviewed journals.
He holds a Bachelor of Medicine and Surgery from Moi University. He holds a Pharmacology Certificate from Tianjin University China. He was a Fogarty trainee in Haematology and Oncology at Brown University, USA.
He trained in Pharmacology and Therapeutics at the Makerere University.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Management of Early Breast Cancer
2022-10-06 08:00 - 17:00
SPEAKER PROFILES:
Dr Miriam Mutebi
Miriam Mutebi is a Consultant Breast Surgical Oncologist and Assistant Professor in the Department of Surgery at the Aga Khan University Hospital in Nairobi, Kenya. She is also a clinical epidemiologist and health systems researcher with a research focus on understanding barriers to access for women with cancers in Sub-Saharan Africa and in designing interventions to mitigate those barriers.
She is the President Elect of the African Organization for Research and Training in Cancer (AORTIC), the Chairperson for the Kenya Society of Hematology and Oncology (KESHO) and on the board of directors of the Union folr International Cancer Control (UICC). She is also the co-founder of the Pan African Women’s Association of Surgeons (PAWAS) which was developed to mentor and provide transformative leadership for women in surgery in order to improve surgical care and pathology on the continent and is part of the Kenya Association of Women Surgeons.
She is the Co-chair of the National Cancer Taskforce in Kenya, Chair of the Commonwealth Taskforce for the elimination of Cervical Cancer and a commissioner with three Lancet commissions of Women and cancer, Cancer in sub-Saharan Africa and Breast Cancer. She is currently pursuing a pilot’s licence in order to extend breast care services to marginalised areas.
Dr Ahmed Komen
Ahmed Komen is a Clinical Radiation Oncologist. He is a fellow of College of Medicine South Africa and holds a Master of Medicine in Radiation Oncology from the University of the Witwatersrand, Johannesburg, South Africa.
He is a Consultant at Kenyatta National Hospital and a part time faculty member at Aga Khan University Hospital.
Dr. Komen is an active member of various multi-disciplinary tumour boards and the Kenya Society of Haematology and Oncology (KESHO).
Moderator: Dr Mwongeli Matheka
Mwongeli Matheka is a General Surgeon at Eldoret Regional Hospital.
She earned her MBChB from the University of Nairobi and Master of Medicine in General Surgery from Aga Khan University.
Dr Matheka has a special interest in breast surgical oncology and improving access to surgical care in the region.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Genetic Testing For Breast Cancer
2022-10-13 19:00 - 20:30
SPEAKER PROFILES:
Dr Mohammed Ezzi
MBCHB, MMed, FMOnC (UoN)
Mohammed Ezzi is a Lecturer and Consultant Medical Oncologist in the Department of Clinical Medicine and Therapeutics at the University of Nairobi in Nairobi, Kenya. He is also the Treasurer for the Kenya Society of Hematology and Oncology (KESHO) and also the Chair for the Educational subcommittee in the same Society.
He did his Internal Medicine residency at the University of Nairobi and subsequently did a two-year fellowship in Medical Oncology at the same university. He is currently a fellow at the College of the European School of Oncology and pursuing a Certificate in Competence in Breast Cancer by the European School of Oncology.
His academic focus is in medical education and is passionate about teaching across the spectrum of medical learners with an interest in enhancing oncologic knowledge amongst non-oncologist. He has presented at several symposia, workshops and conferences both locally and internationally. He has several publications in peer reviewed international journals. Dr. Mohammed Ezzi is a member of KESHO, ASCO, ESMO, AORTIC and KAP. His key areas of interest include breast cancer, malignant hematology and clinical pharmacology.
Dr Catherine Mutinda
MD, M.MED Pediatrics & Child Health, MSc. Medical Genetics & Genomics, DIP. SRHR
Catherine Mutinda serves as a pediatrician within the Nairobi City County and the National Secretary to the Kenya Pediatrics Association board. She received her medical degree from 1st faculty of Medicine, Charles University Prague, the Czech Republic, a Masters of Medicine in Pediatrics and Child Health from the University of Nairobi, and a Master of Science in Medical genetics and genomics from the University of Glasgow, Scotland.
Dr Mutinda has been involved in several operational researches in child health practice. She was involved in setting up the Kangaroo Mother Care and breastmilk bank under one roof at the Pumwani Maternity Hospital, helping the hospital attain the prerequisites a baby- friendly hospital as envisioned by the WHO. She is a reviewer/committee member at the Scientific and Ethics Review Unit – KEMRI. She committed to growing the practice of genetics in Kenya.
Moderator: Dr Naomi Nyambura Kimani
Naomi Kimani is a Clinical Oncologist and Radiation Specialist at Kerugoya County Referral Hospital Cancer Center.
She holds a Bachelor`s degree in Medicine and Surgery from Moi University and Master`s degree in Clinical Oncology from Alexandria University, Egypt.
She is a member of Kenya Society of Haematology and Oncology (KESHO), African Organization for Research and Training in Cancer (AORTIC), and ASCO.
Her main interests are in management of breast cancer, gastrointestinal malignancies, palliative care and radiotherapy.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Optimizing Treatment Outcomes for HR+ and HER2-ve Metastatic Breast Cancer
2022-10-20 19:00 - 20:30
SPEAKER PROFILES:
Dr Amina Kidee
Amina Kidee is a Medical Oncologist at the Aga Khan University Hospital, Mombasa.
Her interests are in breast cancer, GI malignancy, and translational research.
Prof Olivia Pagani
Olivia Pagani was responsible, at the Institute of Oncology of Southern Switzerland (IOSI), for breast cancer medical treatment and clinical research from 2005 to 2019 and of the Clinic for cancer predisposition and high-risk individuals from 2002 to 2019. From 2013 to 2018 she was director of the IOSI Eusoma and Swiss certified Breast Unit and from 2005 to 2008 co-president of the SAKK (Swiss Group for Cancer Research) breast cancer project group.
She is the current coordinator of the breast cancer programme of the European School of Oncology and breast cancer consultant at Hopital Riviera-Chablais, Rennaz, Vaud.
In April 2017 she was nominated Full Professor at the Medical School University of Geneva and in 2019 Full Professor at the Medical School University of Lugano.
Her main research interests in the last years have been breast cancer in young women and advanced breast cancer.
She is panel member of the ESO-ESMO Advanced Breast Cancer (ABC) and chair of the ESO-ESMO Breast Cancer in Young Women Consensus Conferences (BCY). She has been panel member of the San Gallen International Consensus Conference for Early Breast cancer in 2017 and 2019.
Moderator: Dr Siwillis Mithe
Siwillis Mithe is a clinical radiation oncologist at the Nakuru County Teaching and Referral Hospital with particular interest in breast, pediatric, head and neck and neuro-oncology. She has been key in instituting multidisciplinary meetings within the hospital, problem-oriented research in the department and streamlining patient care within oncology clinics.
She holds a Masters of Medicine in Clinical Oncology and is extensively trained in radiation therapy and chemotherapy for a variety of cancers.
Dr Siwillis has interest in research having attended and presented papers at both local and international conferences and also has a number of publications to her name. She has played a key role in the roll out of National Cancer Screening and Treatment guidelines and has been very instrumental in raising cancer awareness across the country. She is an advocate of quality and affordable cancer care for all patients.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Hormonal Therapy in Breast Cancer
2022-10-27 19:00 - 20:30
SPEAKER PROFILES:
Dr Manel Haj Mansour
Manel Haj Mansour is a consultant physician and board certified medical oncologist currently working at the Aga Khan University Hospital. She was formerly a consultant medical oncologist at Texas Cancer Centre, Nairobi and also worked as a consultant medical oncologist and a lecturer at Abderrahmen University Hospital, Tunisia.
Dr. Mansour graduated from the Faculty of Medicine of Tunis in 2012 and completed medical oncology residency in 2017.
She holds:
· A certificate of completion of Oncologic Science Course on line in Breast Cancer
Treatments from The Africa Breast University.
· A certificate of medical oncology training on XXXIIth course antitumor
chemotherapy and cancer medical treatment at Gustave Roussy Institute Paris, France.
· A post graduate certificate in Prevention and Palliative Care in Oncology, Faculty of Medicine of Sousse.
· A post graduate certificate in Thoracic Oncology, Faculty of Medicine of Tunis.
· A post graduate certificate in Breast Disease, Faculty of Medicine of Tunis.
She is a member of ESMO, ASCO, STOM (Tunisian Society of Medical Oncology) and KESHO. Her areas of interest include breast cancer, lung cancer, gastrointestinal cancers, gynecological and genitourinary cancers.
Dr Kevin Makori
Kevin Makori is a Clinical Oncologist at the International Cancer Institute Care and Research Clinic (ICI-CRC), Eldoret Kenya. He is involved in cancer patient care and several ongoing immunooncology and haematology clinical trials as a sub investigator at ICI, under the mentorship of his PI and Director, Prof Chite Asirwa.
He also heads the Education and Training Office at the Institute, and is involved in teaching and coordination of various oncology capacity building activities.
Dr Makori is a member of the Kenya Society of Haematology and Oncology (KESHO), a Global LMIC Associate (Non-Training) Member of the Royal College of Radiologists (RCR) and ASCO. He is a Junior Associate Editor of the RCR’s Clinical Oncology Journal and a current beneficiary of the Journal’s Junior Assistant Editor Mentorship Programme.
He is a visiting Clinical Oncologist at Tenwek Hospital and a member of the Hospital’s oncology multidisciplinary team.
His key professional interests are in radiation sciences, immuno-oncology, clinical trials and oncology education.
He received his postgraduate training (MMed Clinical Oncology) at Muhimbili University of Health & Allied Sciences, a program domiciled at Tanzania’s national oncology referral centre, Ocean Road Cancer Institute, Dar es Salaam.
Moderator: Dr Hilda Mubisi
Hilda Mubisi is a Clinical Oncologist based at the Kakamega Teaching and Referral Hospital.
She holds a Bachelor’s of Medicine and Surgery from Moi University and a Masters in clinical Oncology and nuclear medicine from Alexandria University – Egypt.
Dr Mubisi has interest in breast, colon and gynecological cancers.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Management of Metastatic Non-Small Cell Lung Cancer
2022-11-03 19:00 - 20:30
SPEAKER PROFILES:
Dr Omar Abdihamid
Omar Abdihamid is a Clinical Oncologist at Garissa Cancer Center and HCGCCK Cancer Centre.
He holds a Master’s degree in Clinical Oncology from Central South University, China.
His main areas of interest are Esophageal cancers, Head and Neck cancers, Lung cancer, Genitourinary cancers and Breast cancers.
Dr Omar is passionate about cancer care equity in low- and middle-income countries and advocates for culturally based cancer care. He has a keen interest in Cancer research and has published multiple publications in international peer-reviewed journals.
He is also an a scientific writer, editor and a reviewer for several cancer journals.
Dr Omar is the recipient of the “2021 Journal of Clinical Oncology, ASCO Global Oncology Trainee Journal Reviewer Mentoring Program” and the winner of “Africa ASCO VOICES 2022”– for highlighting state of cancer care in Kenya.
He is a member of:

Kenya Society of Haematology and Oncology (KESHO)
African Organization for Research and Training in Cancer (AORTIC)
European Society of Medical Oncology (ESMO)
American Society of Clinical Oncology (ASCO)

Finally, Dr. Omar is a resident faculty member and tumour board panelist at the International Cancer Institute in Eldoret, Kenya.
Moderator: Dr Helena Musau
Helena Musau is a Consultant Clinical Oncologist working at Kenyatta University Teaching Research and Referral Hospital.
She is also an Adjunct Lecturer at the University of Nairobi, Radiation Oncology program. Dr. Musau is a Member of various Ministry of Health technical working groups aimed at improving access to cancer care in Kenya.
Dr Musau has worked in both the private and public sectors as well as managed oncology and palliative care projects at various levels over the last 13 years.

Breast cancer preceptorship programme in Conjunction with Cairo University
2022-12-08 19:00 - 20:30
SPEAKER PROFILES:
Dr Gladwell Kiarie
Gladwell Kiarie graduated with MBChB (Bachelor of Medicine and Bachelor of Surgery) degrees from The University of Nairobi and went head to receive her post-graduate degree in Internal Medicine from the same institution. After receiving her undergraduate degrees, she did her internship at the Kenyatta National Hospital before proceeding to pursue her fellowship in Medical Oncology in London, England.
After sub-specialization in Medical Oncology, she returned to Kenya where she was one of the founding members of the Oncology Unit at the Aga Khan University Hospital and was also part of the team that set up the first Kenyatta National Hospital Tumor Board in 2007 that involved multiple personnel from surgical and medical departments.
She then joined the University of Nairobi in the Clinical Medicine Department as a Senior Lecturer. Soon afterwards, she enrolled in a PhD program with the Bart’s Cancer Institute under the supervision of Professor John Gribben. She recently received Fellowship to the Royal College of Physicians of Edinburgh (FRCPE).
Dr Kiarie currently runs a private practice at The Nairobi Hospital and also reviews patients at other leading hospitals in Nairobi and Nakuru including The Aga Khan University Hospital, MP Shah Hospital, and Avenue Hospital. She also serves in the Kenya Medical Practitioners and Dentists Board since her appointment in 2015 to the Regulatory Department of the Board.
She is a member of the Kenya Society of Haematology and Oncology (KESHO) where she also served as the treasurer in 2004 and is also a full member of the American Society of Clinical Oncology (ASCO) as well as European Society for Medical Oncology (ESMO).
She continues to be an advocate for early diagnosis of cancer and is greatly involved in programs that focus on providing easy access to basic screening services to the under privileged including setting up oncology services at the county level. In recognition of this, she won the Union for International Cancer Control (UICC) in 2014 for screening in poor settings.
Dr Catherine Nyongesa Watta
Catherine Nyongesa is a Clinical and Radiation Oncologist at Texas Cancer Centre Nairobi and Kenyatta National Hospital, with over 20 years of experience in Oncology conducting inpatient and outpatient management of cancer patients. She has a Bachelor’s degree in Medicine and Surgery (University of Nairobi), Master of Medicine in Radiation Oncology (University of the Witwatersrand, South Africa), and a Fellowship (FC Rad Onc) in Radiation Oncology from the College of Radiation Oncologists of South Africa.
Among the key organizations, she has been a member of the American Society of Clinical Oncology (ASCO), Health Professions Council of South Africa, International Gynecologic Cancer Society, and is former Chair of the Kenya Society of Haematology and Oncology (KESHO).
She has received a number of awards in recognition of her work nationally and globally. These include:

Conquer Cancer Foundation (2011, ASCO Annual Meeting),
IDEA (International Development Education Award- ASCO, 2009)
IGCS (International Gynecologic Cancer Society) Travelling Scholarship Award 2008
Employee excellence award KNH 2007,
MMED dissertation paper passed with distinction 2005 at University of the Witwatersrand, SA.
Best O level and A level student Misikhu Girls High school (St Cecilia)

Dr Catherine Nyongesa is the first female radiation oncologist in Kenya.
She is one of the founders of the Texas Cancer Center Nairobi, and currently holds the position of Head of Department of the Cancer Treatment Centre at Kenyatta National Hospital. She is an Honorary Lecturer at the University of Nairobi and the Project/Program Leader of the American Cancer Society (ACS) Patient Navigation Program at Kenyatta National Hospital. She is also the Regional Project Coordinator for the following International Atomic Energy Agency (IAEA)Project: AFRA- RAF/6/055 on Improving the Quality of Radiotherapy in the Treatment of Frequently Occurring Cancers.
Prof Mohsen Mokhtar
Mohsen Mokhtar is a Professor of Clinical Oncology in Al-Kasr Al-Aini Medical School and Cairo University, Cairo Egypt. Prof Mokhtar assisted in developing the syllabus and course structure at Al-Kasr Al-Aini, as well as, supervised several research programs and theses.
Prof Mokhtar is the managing Director of Cairo University Center of Oncology and Nuclear Medicine NEMROCK and the President of CANSURVIVE.
Prof Mokhtar has published more than 50 articles in several regional magazines in topics including: breast, lung, pediatric, colorectal, ovarian malignancies NHL and hematologic malignancies. Professionally, he has more than 20 years of experience in hospital management. He is currently the chief medical director in Elaj group covering the clinical and medical audit of group facilities.
Dr Loay Kassem
Loay Kassem is an Assistant Professor of Clinical Oncology at Cairo University in Egypt.
He had earned his medical degree from Kasr El Eini Medical School – Cairo University in 2005 and MD in Clinical Oncology from Cairo University in 2016.
Dr Kassem is a Research Fellow in Center Léon Bérard, Lyon, France. He participated as a Co-investigator in several international clinical trials and has authored several scientific papers in international journals.
Moderator: Dr Thomas Odeny
Thomas Odeny is a Senior Principal Clinical Research Scientist at the Kenya Medical Research Institute and also holds a joint appointment as Assistant Professor of Medicine in the Division of Oncology at the Washington University in St. Louis, USA. He is Board Certified in Internal Medicine by the American Board of Internal Medicine and completed his Medical Oncology Fellowship at the US National Cancer Institute/National Institutes of Health.
He holds an MPH and PhD in Epidemiology from the University of Washington in Seattle, USA. He is a member of the American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH), American Association for Cancer Research (AACR), and the International AIDS Society.
He has authored more than 30 peer-reviewed scientific manuscripts. His research has been published in scientific journals such as ‘Journal of ImmunoTherapy of Cancer’, ‘Lancet HIV’, ‘PLOS Medicine’, ‘BMC Medicine’, ‘Implementation Science’, ‘Clinical Infectious Diseases’, ‘Journal of Acquired Immune Deficiency Syndromes’, and ‘Journal of the International AIDS Society’ among others. In recognition of his contribution to research and clinical care, he has received multiple awards including ‘Conquer Cancer Global Oncology Young Investigator Award’, ‘American Society of Clinical Oncology Merit Award’, ‘Sirridge Award for Outstanding Humanistic Qualities – University of Missouri’, ‘Conference on Retroviruses and Opportunistic Infections Young Investigator Award’, and was the first recipient of the ‘Kenya National AIDS Control Council Young Investigator Award’, Kenya’s highest award for young scientists in HIV.
His career vision in Global Oncology is to address gaps in cancer care by translating research advances to practical and scalable cancer programs in low-resource settings in the U.S. and in Africa through high-quality direct patient care and clinical/translational and implementation research.
His clinical research interest is broadly focused on reducing disparities in eligibility for immunotherapy clinical trials and expanding treatment options for cancer in people living with HIV. He is studying the effect of CD4+ T cell count on treatment-emergent adverse events and survival among patients with and without HIV receiving immunotherapy for advanced cancer. This work led to an ASCO Merit Award (2021).
As an ASCO Global Oncology Young Investigator Awardee, Dr. Odeny is also studying the association between Kaposi sarcoma-associated herpesvirus (KSHV) subtypes and clinical severity of disease in patients with KSHV-associated diseases (KAD) in North America and Africa. This will be among the first studies to evaluate KSHV subtype and cytokine profiles as predictors of survival in patients with KAD such as Kaposi sarcoma, primary effusion lymphoma, and KSHV-associated multicentric Castleman disease. By integrating patient clinical characteristics with KSHV genomic analyses, this study will provide a platform for understanding diseases that disproportionately affect low-income, stigmatized, and marginalized communities globally, and are therefore understudied to date.
He is also interested in leading patient and clinician education initiatives in global oncology with plans to establish a formal program in Global Oncology between KEMRI and Washington University in St. Louis. This will be a platform for training of a new generation of globally-oriented physicians who will advance scientific discovery for underserved populations with cancer globally. This will be an important step toward sustaining the potential spread of emerging cancer prevention and therapeutic strategies globally and make a lasting impact.
Prior to pivoting to a career in Global Oncology, Dr. Odeny was in-country PI or co- investigator for multiple NIH-funded trials, including 3 NIH R01s. These trials studied the application of implementation science to promote engagement in the HIV care cascade, and the use of technological innovations to support HIV prevention and treatment efforts. There is a growing recognition that urgent research is needed to find optimal approaches for the translation of efficacious clinical interventions into effective and appropriately scaled programs in the global response to cancer and HIV. As such, Dr. Odeny is interested in leveraging his expertise in implementation science to the growing academic field of global oncology.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

PROSTATE CANCER PRECEPTORSHIP PROGRAMME in Conjunction with Cairo University
2022-12-09 19:00 - 20:30
SPEAKER PROFILES:
Prof Mohamed Abdallah
Mohamed is the Head of Clinical Oncology department at Kasr Al- Aini Center of Oncology and Nuclear Medicine (NEMROCK), Cairo University.
Dr. Mohamed has a special interest and expertise in management of colorectal cancer, advanced head and neck cancers, musculoskeletal cancers and genito-urinary cancers.
Dr Primus Ochieng
Primus Ochieng is the Programme Director of MMed Radiation Oncology training at the University of Nairobi. He is both a lecturer and a consultant clinical oncologist at Kenyatta National Hospital.
He has keen interest in head and neck and prostate cancer treatment. Dr. Ochieng is committed to ensure the program produces well qualified oncologists who will make a difference in cancer treatment in the region. To achieve this, he is keen in collaborating with various centers in the developed world in areas of training, research and skill development.
Prof Alaa Meshref
Alaa Meshref is a Consultant Urologist in multiple institutes and transplant surgeon on Cairo Kidney Center.
He has vast experience in prostate cancer diagnosis with over 20,000 prostate biopsies performed and recently adding cognitive fusion with mpMRI of the prostate across large patient-base patients with BPH and prostate cancer in various stages of the disease.
Prof. Alaa has given more than 20 teaching courses about transrectal ultrasound and prostatic biopsies in conferences and universities. He has presented more than 300 lectures about the early detection of prostate cancer and management of different disease stages
Dr Samuel N. K. Waweru
Samuel Waweru is a Consulting Urologist at the Nairobi Hospital, Mater Hospital among others. He is formerly the chair, Department of Surgery at the Mater Hospital.
Dr Waweru holds a Master’s from the University of Nairobi, urology training from KCMC Moshi, Tanzania.
His interests are in prostatic cancer and urolithiasis.
Moderator: Dr Tracy Irura
Tracy Irura is a Senior Registrar in Clinical Oncology at Kenyatta University Teaching, Research and Referral Hospital.
She holds a Master’s in Clinical Oncology and Nuclear Medicine from Alexandria University, Egypt.
Dr Irura is the co-founder of the Integrated Cancer Research Foundation of Kenya an NGO that seeks to rid Africa of the cancer burden and be a leading cancer research organization in the world.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Management/Updates in Treatment of Early Cervical Cancer
2023-01-26 19:00 - 20:30
SPEAKER PROFILES:
Dr Catherine Nyongesa
Catherine Nyongesa is a Clinical and Radiation Oncologist at Texas Cancer Centre Nairobi and Kenyatta National Hospital, with over 20 years of experience in Oncology conducting inpatient and outpatient management of cancer patients. She has a Bachelor’s degree in Medicine and Surgery (University of Nairobi), Master of Medicine in Radiation Oncology (University of the Witwatersrand, South Africa), and a Fellowship (FC Rad Onc) in Radiation Oncology from the College of Radiation Oncologists of South Africa.
Among the key organizations, she has been a member of the American Society of Clinical Oncology (ASCO), Health Professions Council of South Africa, International Gynecologic Cancer Society, and is former Chair of the Kenya Society of Haematology and Oncology (KESHO).
She has received a number of awards in recognition of her work nationally and globally. These include:

Conquer Cancer Foundation (2011, ASCO Annual Meeting),
IDEA (International Development Education Award- ASCO, 2009)
IGCS (International Gynecologic Cancer Society) Travelling Scholarship Award 2008
Employee excellence award KNH 2007,
MMED dissertation paper passed with distinction 2005 at University of the Witwatersrand, SA.
Best O level and A level student Misikhu Girls High school (St Cecilia)

Dr Catherine Nyongesa is the first female radiation oncologist in Kenya.
She is one of the founders of the Texas Cancer Center Nairobi, and currently holds the position of Head of Department of the Cancer Treatment Centre at Kenyatta National Hospital. She is an Honorary Lecturer at the University of Nairobi and the Project/Program Leader of the American Cancer Society (ACS) Patient Navigation Program at Kenyatta National Hospital. She is also the Regional Project Coordinator for the following International Atomic Energy Agency (IAEA)Project: AFRA- RAF/6/055 on Improving the Quality of Radiotherapy in the Treatment of Frequently Occurring Cancers.
Dr Peter Itsura
Peter Itsura is an Obstetrician/Gynaecologist and Gynaecologic Oncologist. He works in the Department of Reproductive Health at Moi University School of Medicine, College of Health Sciences. He is a Lecturer and Acting Chair of Department. He teaches and offer clinical services at the Moi Teaching and Referral Hospital.
Dr Itsura is the current deputy Chair, Division of Gynaecologic Oncology and deputy lead AMPATH Cervical Cancer Prevention Program (ACCP) with screening clinics spread throughout the AMPATH Catchment are in Western Kenya.
He started the first Clinical Fellowship at Moi University in collaboration with his colleague and other North American partners from the University of Toronto. This was not only the first such training in Kenya but indeed in the region.
Moderator: Dr Jackline Makokha
Jackline Makokha is Clinical Oncologist at Jaramogi Oginga Odinga Teaching and Referral Hospital and Synergy Clinics in Kisumu.
She holds an MBCHB from University of Nairobi and MPH degree from the University of Liverpool (UK) from where her thesis work on Triple Negative Breast cancer led her to pursue a Masters in Clinical Oncology and Nuclear Medicine from Alexandria University (Egypt).
Her interests are in Breast, Prostate, Cervical and Colorectal cancer.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Lung Cancer
2023-02-09 19:00 - 20:30
SPEAKER PROFILES:
Dr Naftali Busakhala
Naftali Busakhala is a Senior Lecturer and specialist Physician at Moi University and Moi Teaching and Referral Hospital. He is the departmental postgraduate coordinator at the department of pharmacology and toxicology at Moi University. He is the co-chairman of the Ampath Oncology working group. Dr Busakhala is the principal investigator of the AIDS Malignancy Consortium, Moi University Site. He is also the principal investigator of the Lung and Breast Cancer Projects.
Dr Busakhala is also a Senior Research Fellow at the Institute of Prevention and Research, Lyon France. He has published widely in peer reviewed journals.
He holds a Bachelor of Medicine and Surgery from Moi University. He holds a Pharmacology Certificate from Tianjin University China. He was a Fogarty trainee in Haematology and Oncology at Brown University, USA.
He trained in Pharmacology and Therapeutics at the Makerere University.
Dr Kevin Makori
Kevin Makori is a Clinical Oncologist at the International Cancer Institute Care and Research Clinic (ICI-CRC), Eldoret Kenya. He is involved in cancer patient care and several ongoing immunooncology and haematology clinical trials as a sub investigator at ICI, under the mentorship of his PI and Director, Prof Chite Asirwa.
He also heads the Education and Training Office at the Institute, and is involved in teaching and coordination of various oncology capacity building activities.
Dr Makori is a member of the Kenya Society of Haematology and Oncology (KESHO), a Global LMIC Associate (Non-Training) Member of the Royal College of Radiologists (RCR) and ASCO. He is also a Junior Associate Editor of the RCR’s Clinical Oncology Journal and a current beneficiary of the Journal’s Junior Assistant Editor Mentorship Programme.
Dr Makori is a visiting Clinical Oncologist at Tenwek Hospital and a member of the Hospital’s oncology multidisciplinary team.
His key professional interests are in radiation sciences, immuno-oncology, clinical trials and oncology education.
He received his postgraduate training (MMed Clinical Oncology) at Muhimbili University of Health & Allied Sciences, a program domiciled at Tanzania’s national oncology referral centre, Ocean Road Cancer Institute, Dar es Salaam.
Prof Mohsen Mokhtar
Mohsen Mokhtar is a Professor of Clinical Oncology in Al-Kasr Al-Aini Medical School and Cairo University, Cairo Egypt. Prof Mokhtar assisted in developing the syllabus and course structure at Al-Kasr Al-Aini, as well as, supervised several research programs and theses.
Prof Mokhtar is the Managing Director of Cairo University Center of Oncology and Nuclear Medicine NEMROCK and the President of CANSURVIVE.
Prof Mokhtar has published more than 50 articles in several regional magazines in topics including: breast, lung, pediatric, colorectal, ovarian malignancies NHL and hematologic malignancies. Professionally, he has more than 20 years of experience in hospital management. He is currently the chief medical director in Elaj group covering the clinical and medical audit of group facilities.
Dr Ahmed Magdy
Ahmed Magdy is an Assistant Professor of Medical Oncology and Hematology in the National Cancer Institute, Cairo University and currently holding the position of Vice Chair of Medical Oncology department in Baheya Cancer Center and Chair of Career Development and Fellowship program in the International Association for the Study of Lung Cancer (IASLC).
He started his career in 2006 as a resident of Medical Oncology and Hematology in the National Cancer Institute where he achieved his Master’s degree in 2009. In 2011, he completed his clinical fellowship in hematology from Princess Margaret Hospital, Toronto University, Canada followed in 2012 by 2nd Masters Degree from Ulm University, Ulm, Germany. In 2015 Dr Magdy obtained his PhD.
He held the position of Head of Medical Oncology Department in Shefa El Orman Hospital, Luxor from 2017 to 2020, then went on to become the Medical Director from 2020 till 2021.
Dr Magdy has published more than 17 articles and case presentations, reviewer in peer reviewed journals, in addition to being a speaker in many conferences both nationally and internationally. His main area of focus is Lung cancer, breast cancer and malignant hematology.
Moderator: Dr Manel Haj Mansour
Manel Haj Mansour is a Consultant Physician and board certified Medical Oncologist currently working at the Aga Khan University Hospital. She was formerly a consultant medical oncologist at Texas Cancer Centre, Nairobi and also worked as a consultant medical oncologist and a lecturer at Abderrahmen University Hospital, Tunisia.
Dr. Mansour graduated from the Faculty of Medicine of Tunis in 2012 and completed medical oncology residency in 2017. She holds:
· A certificate of completion of Oncologic Science Course on line in Breast Cancer
Treatments from The Africa Breast University.
·A certificate of medical oncology training on XXXIIth course antitumor
chemotherapy and cancer medical treatment at Gustave Roussy Institute Paris, France.
· A post graduate certificate in Prevention and Palliative Care in Oncology, Faculty of Medicine of Sousse.
· A post graduate certificate in Thoracic Oncology, Faculty of Medicine of Tunis.
· A post graduate certificate in Breast Disease, Faculty of Medicine of Tunis.
She is a member of KESHO, ESMO, ASCO, STOM (Tunisian Society of Medical Oncology). Her areas of interest include breast cancer, lung cancer, gastrointestinal cancers, gynecological and genitourinary cancers.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

International Childhood Cancer Day - Wilm's Tumour
2023-02-16 19:00 - 20:30
SPEAKER PROFILES:
Dr Irene Nzamu
Irene Nzamu is a Pediatric Hematologist Oncologist. She is the Head of the Pediatric Hemato Oncology Unit at the Kenyatta National Hospital.
Dr Nzamu attained her undergraduate training (MBChB) & postgraduate training (M.MED) at The University of Nairobi. She did her Fellowship in Pediatric Hematology & Oncology at Makerere University in collaboration with Baylor College of Medicine & Global HOPE Texas Children’s Hospital.
She is passionate about offering evidence based, affordable care for children with cancer & blood diseases in our resource limited settings.
Dr Francisca Munyalo
Francisca Syovata Munyalo is a Paediatric Surgeon at the Kenyatta National Hospital.
Dr Munyalo attained her undergraduate training (MBChB) & postgraduate training (M.MED) at The University of Nairobi.
She is passionate about surgical oncology and neonatal surgery and is involved in surgical outreaches with the aim of building the capacity of Paediatric Surgery in Kenya.
Moderator: Dr Catherine Muendo
Catherine Muendo is a Paediatric Hematologist and Oncologist who completed her fellowship training at Makerere university in collaboration with Mulago National Referral Hospital, Baylor college of medicine and Texas cancer children’s hospital.
She works as a consultant paediatrician at Kenyatta National Hospital. Dr Muendo received her medical degree (MBChB) and pediatrics and child health degree (MMed) at the University of Nairobi.
She is enthusiastic about improving the outcomes of children with blood and cancer disorders in Kenya through novel interventions that are sustainable in a resource limited setting.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

International Women's Day
2023-03-02 19:00 - 20:30
SPEAKER PROFILES:
Dr Afrin Shaffi
Afrin Shaffi is a gynecologic oncologist based in Kwale county. She completed her undergraduate studies at Manipal College of Medical Sciences in Nepal and proceeded to do her postgraduate training in Obstetrics and Gynecology at Muhimbili University of Health and Allied Sciences in Tanzania.
She did her fellowship in Gynecologic Oncology at Moi University/Moi Teaching and Referral hospital, in Eldoret as well as successfully completed the International Gynecologic Cancer Society, IGCS, fellowship.
She is an active member of the Kenya Obstetrical and Gynecological Society, KOGS, the International Gynecologic Cancer Society (IGCS) and the American Society of Clinical Oncology (ASCO).
She is currently the country lead for the international Every Woman Study in Kenya in collaboration with World Ovarian Cancer Coalition and IGCS. Dr. Shaffi is a recipient of the NIH grant under the U54 mentorship program. She has headed several outreach clinics and provided free services in underserved areas of Kenya and as an ambassador for MSF to international sites like Malawi.
Her areas of interests include ovarian and cervical cancer.
Dr Jyoti Wadhwa
Jyoti Wadhwa is a Senior Director in Medical Oncology & Hemato Oncology at Medanta – Gurugram, India.
She has more than 20 years’ experience in oncology, she is specialised in solid tumours including- breast, ovary, lung, cancer of head and neck, GI tract, prostate, bone & brain tumours.
She trained at the prestigious AIIMS New Delhi for both her MD and DM training, and skilled in Oncology, Healthcare Management, Healthcare Internal Medicine, and Clinical Research.
She has also authored a book on breast cancer and has many other publications in national & international journals of repute.
She has a Commonwealth Scholarship from Imperial College School of Medicine, Hammersmith Hospital, London. Dr Jyoti Wadhwa is a member of National Academy of Medical Sciences, New Delhi, American Society of Clinical Oncology (ASCO), European Society of Medical Oncology (ESMO) ,Life Member of Indo American Cancer Association & Delhi Medical Association and a Working Committee Member of Indian Journal of Medical and Paediatric Oncology.
She is winner of various awards like Lady Willingdon Gold Medal, MMRF Travel Grant by the Multiple Myeloma Research Foundation, USA, CSIR Full Travel Grant by Council for Scientific & Industrial Research new Delhi, to name a few.
Dr Jyoti is an author and compassionate clinician.
Moderator: Dr Khadija Warfa
Khadija Warfa is a Consultant Gynecologic Oncologist, who completed her gynaecological oncology fellowship at the University of Calgary, Canada.
Currently Dr. Warfa is an Assistant Professor in the Department of Obstetrics and Gynecology at The Aga Khan University Hospital, where she had done her Obstetrics and Gynecology residency training. She is involved in the training and supervision of postgraduate students.
Dr. Warfa is a member of the Kenya Society of Haematology and Oncology (KESHO) and the African Cancer Coalition and European society of gynecologic oncology (ESGO). She is involved in the Harmonized NCCN guidelines and is a technical advisor to the Kenya National cancer treatment protocols with the objective to reduce mortality related to Gynecologic Cancers in Kenya.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Metastatic Colon Cancer
2023-03-09 18:30 - 21:00
SPEAKER PROFILES:
Dr Karan Gandhi
Karan R. K. Gandhi is a Consultant General and Hepatobiliary Surgeon at the Department of Surgery, Aga Khan University Hospital, Nairobi.
Dr. Gandhi graduated from The University of Nairobi to receive his medical degree in 2009 and did a year of internship at the Aga Khan University Hospital, Nairobi (AKUH,N) in 2010. He began his surgical training at the University of Nairobi in 2011 and then moved to the University of Cape Town in 2013. He qualified as a Fellow of the College of Surgeons of South Africa in 2018 and then went on to complete his subspecialist certificate training in Surgical Gastroenterology, specifically Hepato-Pancreatico-Biliary (HPB) Surgery, in 2020. He also received a Masters degree in Surgery (MMed) from the University of Cape Town in 2020. In the same year, Dr. Gandhi was also selected to represent Sub-Saharan Africa (SSA) in the IHPBA 2020 International Fellows Retreat in Melbourne, Australia. His main clinical interests lie in Hepatic, Pancreatic and Biliary surgery, as well as gastrointestinal surgery, advanced endoscopy, ERCP and laparoscopy. Within the realm of HPB surgery, his primary focus has been on one of the most neglected diseases in the region, namely hepatocellular carcinoma (HCC). In the Global Surgery 2030 document published by The Lancet Commission in 2015, eastern, western and central SSA were identified as the regions in the world with the greatest unmet needs in surgical care and in a strange coincidence, these are also the regions in SSA with the highest HCC incidence.
Dr. Gandhi has recently joined the AKUH,N as a full-time faculty member in the department of General Surgery, with a view to pioneering and developing HPB Surgery in Kenya, East Africa and SSA as a whole. He sees himself as one of a new generation of HPB surgeons that have a vision of changing the situation in SSA, where delivering a surgical service is hampered by a poorly managed and funded healthcare system, cost of treatment and a shortage of healthcare professionals. With the connections made during his training and the vision and guidance of his mentors, Dr. Gandhi looks forward to creating a network of young HPB surgeons to facilitate this important endeavour. He has helped set up and is currently involved in various multi-disciplinary team (MDT) meetings, including a monthly Sub-Saharan HCC meeting and an international collaborative HCC meeting with Fortis Hospitals in India. He is also actively involved with the HPB service and MDT meetings at the Kenyatta National Hospital, Kenya.
Dr. Gandhi is also passionate about teaching and training of young surgeons in Kenya, especially in the fields of laparoscopy and surgical endoscopy delivery in rural areas. He is a member of the Operating Theatre Practitioners Association of Kenya (OTPAK), where training workshops are organised for surgical trainees in the Kenyan College of Surgeons of East, Central and Southern Africa (COSECSA), in order to train and empower them to perform basic laparoscopic surgical procedures in rural centres. His role as a faculty member at the AKUH,N also includes supervision and training of surgical residents, thereby promoting academia alongside clinical service delivery. He plans to set up a surgical registry database in the hospital, which will be used to generate data, audit practice and produce high-quality research that can be published in reputable peer-reviewed journals.
With his solid background, training, passion and networking, Dr. Gandhi believes he is a key player in taking HPB surgery forward on the continent of Africa.
Dr Andrew Odhiambo
Andrew Odhiambo is a Consultant Physician/Medical Oncologist & Program Director/Lecturer (Medical Oncology Fellowship Program) at the University of Nairobi. Dr. Andrew holds a Master’s degree in Internal Medicine from the University of Nairobi. He has attended preceptorship training in Haematological Oncology & Infectious Diseases from the University of Maryland Marleen & Stewart Greenbaum Cancer Centre in the United States. He later did his Fellowship in Medical Oncology in the United Kingdom and was certified by the Federation of Royal College of Physicians of the United Kingdom as well as the Association of Cancer Physicians and the European Society for Medical Oncology. He is also a Fellow of the Royal College of Physicians of Edinburgh as well as the East, Central & Southern Africa College of Physicians.
He is the outgoing Secretary & former Treasurer of Kenya Society of Haematology & Oncology (KESHO). Dr. Andrew is a member of KAP, ASCO, ESMO, AORTIC & ECSACOP. Dr. Andrew serves as an expert advisor for local and international bodies i.e. MOH, Kenya Cancer Prevention TWG, ASCO & NCCN Cancer Treatment Guidelines Committees. He has published several articles on cancer in both international and local peer reviewed scientific journals.
Dr. Andrew was awarded the prestigious Business Daily Africa Top 40 under 40 men in the year 2017. He is passionate about cancer education and awareness especially through digital platforms. He has over 50 appearances in mainstream local and international TV and print media promoting cancer awareness.
His key areas of sub specialization and interest include Colon cancer, Stomach cancer, Breast Cancer, Pancreatic, Liver & Bile Duct cancer, Cancer or Unknown Primary, Lymphoma as well as newer treatments i.e. Immunotherapy & Targeted therapy for Colon, Skin, Lung, Kidney cancers etc. For his full profile, please visit www.drandrewodhiambo.com
Dr Manel Haj Mansour
Manel Has Mansour is a Consultant Physician and board-certified Medical Oncologist currently working at the Aga Khan University Hospital. She was formerly a consultant medical oncologist at Texas Cancer Centre, Nairobi and also worked as a consultant medical oncologist and a lecturer at Abderrahmen University Hospital, Tunisia.
Dr. Mansour graduated from the Faculty of Medicine of Tunis in 2012 and completed medical oncology residency in 2017.
She holds:
· A certificate of completion of Oncologic Science Course on line in Breast Cancer
Treatments from The Africa Breast University.
· A certificate of medical oncology training on XXXIIth course antitumor
chemotherapy and cancer medical treatment at Gustave Roussy Institute Paris, France.
· A post graduate certificate in Prevention and Palliative Care in Oncology, Faculty of Medicine of Sousse.
· A post graduate certificate in Thoracic Oncology, Faculty of Medicine of Tunis.
· A post graduate certificate in Breast Disease, Faculty of Medicine of Tunis.
She is a member of ESMO, ASCO, STOM (Tunisian Society of Medical Oncology) and KESHO. Her areas of interest include breast cancer, lung cancer, gastrointestinal cancers, gynecological and genitourinary cancers.
Dr Ahmed Komen
Dr Ahmed Komen is a Clinical Radiation Oncologist. He is a fellow of College of Medicine South Africa and holds a Master of Medicine in Radiation Oncology from the University of the Witwatersrand, Johannesburg, South Africa.
Dr Komen is a consultant at Kenyatta National Hospital and a part time faculty member at Aga Khan University Hospital.
He is an active member of various multi-disciplinary tumour boards and the Kenya Society of Haematology and Oncology (KESHO).
Moderator: Dr Tracy Irura
Tracy Irura is a Senior Registrar in Clinical Oncology at Kenyatta University Teaching, Research and Referral Hospital.
She holds a Master’s in Clinical Oncology and Nuclear Medicine from Alexandria University, Egypt.
Dr Irura is the co-founder of the Integrated Cancer Research Foundation of Kenya an NGO that seeks to rid Africa of the cancer burden and be a leading cancer research organization in the world.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal

Multiple Myeloma
2023-03-16 19:00 - 20:30
SPEAKER PROFILES:
Dr Angela McLigeyo
Angela McLigeyo is a licensed Physician and Medical Oncologist practicing in Kenya. She has a Master of Medicine in Internal Medicine from the University of Nairobi, a M.Sc. in Clinical Oncology from Ulm University (Germany), and a Fellowship in Medical Oncology from the University of Nairobi. In addition, she obtained a 5-year board certification in Medical Oncology from ESMO in 2019. She has over 17 years of experiences in hospital and clinical settings.
She is a member of the Kenya Society of Haematology and Oncology (KESHO), European Society of Medical Oncology (ESMO) and American Society of Clinical Oncology (ASCO). She is also a fellow of the East, Central and Southern Africa College of Physicians.
Her core skills are in clinical decision making in internal medicine and oncology, conducting trainings, streamlining medical education and conducting research as well as participation in the development of treatment guidelines and protocols.
Dr McLigeyo currently provides comprehensive oncology healthcare at both public and private health facilities, conducts research in oncology and internal medicine when opportunities arise, and is engaged in teaching internal medicine and oncology at the Kenyatta University. She has authored several research articles in peer reviewed journals and presented abstracts at several conferences.
Dr Rohini Radia
Rohini Radia completed her medical degree and postgraduate sub-specialty training in the UK. She obtained her MBChB degree in 1999. She continued with postgraduate training and obtained the MRCP (UK) qualification in internal medicine in 2005. She was a Specialist Registrar in haematology on a 5 year training programme at University Hospitals Bristol NHS Trust and obtained FRCPath(Haem) in 2005.
During her haematology training and work as a consultant, she pursued an interest in malignant haematology and allogeneic transplantation. She has extensive experience in haematology with a special interest in myeloid malignancies and bone marrow transplantation, including 10 years at consultant level at The Russell Centre for Clinical Haematology, Nottingham University Hospitals NHS Trust. Dr Radia is a Kenyan and is keen to contribute her clinical expertise where there is a huge unmet clinical need in the area of stem cell transplantation. In January 2023, she returned home and started as BMT Consultant at the The Nairobi West Hospital.
Her BMT experience spans all aspects of stem cell transplantation from patient and donor selection to appropriate selection of conditioning protocol, GVHD prophylaxis and post-transplant management of immune suppression, acute and chronic GVHD and late effects. She worked closely with the Anthony Nolan transplant registry. She was the lead consultant for myelodysplasia, GVHD and apheresis. Dr Radia carried out the first syngeneic stem cell transplant at Nottingham University Hospitals NHS Trust. Clinical research has been an interest she has consolidated by active participation in clinical trials.
Moderator: Dr Grace Kiraka
Grace Kiraka is a consultant clinical pathologist working at the M P Shah hospital.
She has a master’s in clinical pathology [Mmed Clin Path] from the Aga Khan University Hospital Nairobi and specializes in the diagnosis of blood and bone marrow disorders. Dr Kiraka has a keen interest in therapeutic apheresis and has been carrying out red cell exchange transfusions for patients living with Sickle Cell Disease at the M P Shah hospital. She hopes this therapy will soon be available to all patients with SCD that need it across the country.

Recording

Dear Guest, this content is restricted to only KESHO Members.
Access our Membership Page

Fill in the Membership Form

Access Membership Portal
